An 18-gene signature predicted the clinical outcome in stage 4 neuroblastoma [29] and found ERCC6L, AHCY, STK33, and NCAN as a set of genes that could be used to predict prognosis in neuroblastoma patients [30]. Here, ERCC6L is linked to neuroblastoma.